ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

SBRA vs PECO // GROSS PROFIT MARGIN

Sabra Health Care REIT Inc. (NASDAQ) VS. Phillips Edison & Company Inc. (NASDAQ) • 15-METRIC TALLY: SBRA 4 — PECO 4
■ METRIC PARITY
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (SBRA VS. PECO) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC SBRA PECO SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin ACTIVE — — — TIE /gross-margins <GO>
Return on Invested Capital (ROIC) 5.50% 4.90% +0.60 SBRA /roic <GO>
EV/EBITDA & P/E Valuation — — — TIE /valuation <GO>
Free Cash Flow Yield 6.96% 6.97% -0.01 PECO /fcf-yield <GO>
Operating Margin — — — TIE /operating-margins <GO>
Net Profit Margin 43.60% 68.00% -24.40 PECO /net-margins <GO>
Revenue Growth (YoY) 25.40% 18.80% +6.60 SBRA /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 5.78% 3.15% +2.63 SBRA /dividend-safety <GO>
Altman Z-Score & Debt/Equity — — — TIE /balance-sheet <GO>
Piotroski F-Score Quality 6/9 6/9 0.00 TIE /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 53.3 64.1 -10.80 PECO /rsi-technicals <GO>
10Y Yield & FRED Macro Beta — — — TIE /macro-sensitivity <GO>
Forward P/E Multiple 27.0x 37.7x -10.70 SBRA /forward-pe <GO>
Enterprise Scale & Market Cap $5.04B $5.12B -$81.0M PECO /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR SBRA REV PECO REV SBRA GROSS % PECO GROSS % SBRA FCF PECO FCF
FY 2025 $356.9M $12.8M — — $348.6M $348.1M
FY 2024 $284.6M $10.7M — — $310.5M $334.7M
FY 2023 $236.2M $9.6M — — $300.6M $291.0M
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
SBRA // BETA —
PECO // BETA —